Clearmind Medicine Inc (CMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2023 | 10-2022 | 10-2021 | 10-2020 | 10-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 42 | 83 | 2 | N/A | N/A |
| Income taxes - deferred | 13 | 30 | N/A | N/A | N/A |
| Accounts receivable | -112 | 20 | -127 | 0 | 4 |
| Accounts payable and accrued liabilities | -449 | 916 | 277 | -6 | 4 |
| Other Working Capital | -701 | 1,240 | 21 | -23 | 32 |
| Other Operating Activity | -3,350 | -6,025 | -2,461 | -169 | -88 |
| Operating Cash Flow | $-4,557 | $-3,735 | $-2,288 | $-199 | $-48 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -6 | -27 | -8 | -8 |
| Purchase Sale Intangibles | 0 | 0 | -160 | N/A | N/A |
| Other Investing Activity | -19 | 0 | -16 | 4 | 0 |
| Investing Cash Flow | $-19 | $-6 | $-203 | $-4 | $-8 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -30 | -57 | N/A | N/A | N/A |
| Common Stock Issued | 8,037 | 584 | 6,233 | 488 | 0 |
| Other Financing Activity | 427 | -14 | -298 | -39 | 0 |
| Financing Cash Flow | $8,434 | $513 | $5,936 | $449 | $0 |
| Exchange Rate Effect | -27 | -23 | N/A | N/A | N/A |
| Beginning Cash Position | 93 | 3,380 | 266 | 1 | 56 |
| End Cash Position | 3,925 | 129 | 3,727 | 248 | 1 |
| Net Cash Flow | $3,859 | $-3,228 | $3,461 | $247 | $-55 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,557 | -3,735 | -2,288 | -199 | -48 |
| Capital Expenditure | N/A | -6 | -187 | -8 | -8 |
| Free Cash Flow | -4,557 | -3,741 | -2,474 | -206 | -55 |